See up to 3 months of NUVB. The 7-day demo opens the 1M and 3M ranges and puts NUVB on your watchlist.
Start 7-day demoLatest NUVB insider trades
About Nuvation Bio Inc. (NUVB)
Nuvation Bio Inc. files with the SEC under CIK 0001811063 and is classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
NUVB Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 1 | 100,000 | $709K |
| Option exercise | 6 | 280,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
NUVB insider transactions (Form 4)
1738 Form 4 filings on record, the earliest from Oct 9, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dongfang Liu - Officer | Option exercise | Stock Option (Right to Buy) | 15,000 | $0.00 | - | |
| Dongfang Liu - Officer | Option exercise | Stock Option (Right to Buy) | 15,000 | $0.00 | - | |
| Dongfang Liu - Officer | Open-market sale | Class A Common Stock | 15,000 | $4.77 | $71K | |
| Dongfang Liu - Officer | Option exercise | Class A Common Stock | 15,000 | $1.87 | $28K | |
| Dongfang Liu - Officer | Option exercise | Class A Common Stock | 15,000 | $1.87 | $28K | |
| Dongfang Liu - Officer | Open-market sale | Class A Common Stock | 15,000 | $5.10 footnote F2 | $77K | |
| ||||||
| Gary Hattersley - Officer | Option exercise | Stock Option (Right to Buy) | 100,000 | $0.00 | - | |
| Gary Hattersley - Officer | Option exercise | Class A Common Stock | 100,000 | $1.74 | $174K | |
| Gary Hattersley - Officer | Open-market sale | Class A Common Stock | 100,000 | $5.02 footnote F2 | $502K | |
| ||||||
| Robert Mashal | Gift | Stock Option (Right to Buy) | 350,001 | $0.00 | - | |
| Robert Mashal | Gift | Stock Option (Right to buy) | 350,001 | $0.00 | - | |
| Kim D. Blickenstaff | Grant or award | Stock Option (Right to Buy) | 292,983 | $0.00 | - | |
| Kathryn E. Falberg | Grant or award | Stock Option (Right to Buy) | 292,983 | $0.00 | - | |
| Junyuan Jerry Wang - Officer | Open-market sale | Class A Common Stock | 56,361 | $2.89 | $163K | |
| Robert Mashal | Open-market purchase | Class A Common Stock | 19 | $2.20 | $42 | |
| Robert Mashal | Open-market purchase | Class A Common Stock | 99,981 | $2.20 | $220K | |
| Philippe Sauvage - Officer | Grant or award | Stock Option (Right to Buy) | 750,000 | $0.00 | - | |
Recent NUVB Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| GARY HATTERSLEY | Officer | 100,000 | $696K | View on EDGAR | |
| - | - | - | - |
NUVB insider trading FAQ
What is the latest insider trade for NUVB?
Nuvation Bio Inc. (NUVB) had 2 insider filings in the last 90 days, with the most recent on 2026-08-21. The full record for NUVB runs to 38 Form 4 filings, the earliest from 2024-10-09. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying NUVB stock?
No insider purchases of NUVB were filed in the last 90 days. 3 purchases are on record for this company.
How many insiders are selling NUVB stock?
1 insider sale of NUVB was filed in the last 90 days, totaling $709K.
Where can I see NUVB SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects NUVB Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Gary Hattersley view on EDGAR
- - Philippe Sauvage view on EDGAR
- - Stacy Markel view on EDGAR
- - Kerry Wentworth view on EDGAR
- - Philippe Sauvage view on EDGAR
- - Robert Mashal view on EDGAR
- - W. Anthony Vernon view on EDGAR
- - Robert Mashal view on EDGAR
- - Kathryn E. Falberg view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where NUVB's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow NUVB with a 7-day demo
- NUVB on your watchlist
- Every NUVB Form 4 filing on record
- Up to 3 months of NUVB price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
